Burke, M. J., Devidas, M., Maloney, K., Angiolillo, A., Schore, R., Dunsmore, K., . . . Bleyer, A. (2017). Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: Analysis of 54,280 doses administered to 16,534 patients on children’s oncology group (COG) clinical trials. Leuk Lymphoma.
Citação norma ChicagoBurke, Michael J., et al. "Severe Pegaspargase Hypersensitivity Reaction Rates (grade ≥3) With Intravenous Infusion Vs. Intramuscular Injection: Analysis of 54,280 Doses Administered to 16,534 Patients On Children’s Oncology Group (COG) Clinical Trials." Leuk Lymphoma 2017.
Deismireacht MLABurke, Michael J., et al. "Severe Pegaspargase Hypersensitivity Reaction Rates (grade ≥3) With Intravenous Infusion Vs. Intramuscular Injection: Analysis of 54,280 Doses Administered to 16,534 Patients On Children’s Oncology Group (COG) Clinical Trials." Leuk Lymphoma 2017.